相关实验视频

Updated: Jun 7, 2025

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique

Published on: September 23, 2022

疫苗接种作为患儿多发性硬化症的危险因素:从回顾性病例控制研究的见解

Sonia Darvishi¹, Ewan Donnachie², Christiane Gasperi¹

¹Department of Neurology, Klinikum rechts der Isar, School of Medicine and Health, Technical University of Munich, Munich, Germany.

Multiple sclerosis (Houndmills, Basingstoke, England)

|November 14, 2024

概括

这项研究发现,在儿童接种疫苗后,儿童多发性硬化症 (MS) 的风险没有增加. 对德国健康数据的分析显示了负相关性,不支持疫苗接种是儿童多发性硬化症的原因.

科学领域:

神经学神经学
免疫学免疫学免疫学
儿科儿科儿科

背景情况:

儿科多发性硬化症 (MS) 是一种罕见但严重的自身免疫性疾病,影响儿童和青少年.
人们仍然担心MS的潜在环境触发因素,包括儿童疫苗接种.
了解疫苗接种和儿科MS之间的关系对于公共卫生和家长指导至关重要.

研究的目的:

调查儿童疫苗接种与患儿多发性硬化症的风险之间的关联.
通过使用现实世界健康数据来确定疫苗接种是否是儿童多发性硬化症的危险因素.

主要方法:

德国门诊医疗索赔数据的回顾性分析.
包括346名被诊断患有儿科MS的9-17岁儿童.
使用后勤和Poisson回归模型与对照组 (克罗恩病,牛皮,没有自身免疫性疾病).

主要成果:

在疫苗接种状态和儿科MS诊断之间观察到负相关性.
疫苗接种后没有发现儿童多发性硬化症的统计学上显著增加的风险.
敏感性分析和临床隔离综合征分析证实了主要发现.

结论:

该研究的结果不支持疫苗接种是患儿多发性硬化症的危险因素的假设.
研究结果表明,儿童疫苗接种与患儿多发性硬化症的风险增加无关.
这项研究提供了基于证据的关于儿童神经系统自身免疫性疾病疫苗安全性的信息.

关键词:

儿科多发性硬化症儿童多发性硬化症诊断诊断诊断诊断诊断诊断接种疫苗接种疫苗

更多相关视频

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

相关概念视频

Vaccinations

Vaccinations

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...